The usage of ALT as a surrogate of sarcopenia and its ability to predict extubation outcome is limited to patients with low ALT; however, some sarcopenic patients may have elevated ALT due to hepatic damage which is not uncommon in critically ill patients. This evidence concerns the gene GPT and sarcopenia.